<DOC>
	<DOCNO>NCT02835274</DOCNO>
	<brief_summary>The primary objective characterize program effect Boston Scientific Vercise™ PC System use DBS Directional Lead bilateral STN DBS treatment Parkinson 's disease acute chronic setting .</brief_summary>
	<brief_title>Study Characterize Acute Chronic Directional Aspects Deep Brain Stimulation</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Key Diagnosis bilateral idiopathic PD presence rigidity least one ( 1 ) following : rest tremor bradykinesia . UPDRS III score &gt; 25 med OFF condition Medication must improve PD symptom ≥30 % , measure UPDRS subset III score Key Any significant psychiatric problem , include unrelated clinically significant depression determine investigator Any current drug alcohol abuse determine investigator Any history recurrent unprovoked seizures Any significant medical condition likely interfere study procedure likely confound evaluation study endpoint , include terminal illness survival &lt; 12 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>parkinson disease</keyword>
	<keyword>deep brain stimulation</keyword>
	<keyword>directional stimulation</keyword>
</DOC>